PortViewPortView
Nexalin Technology logo

Nexalin Technology (NXLIW) Stock Analysis

NASDAQHealthcareMedical - Devices

$0.01-9.21%
1-year price historyRange $0.01 – $0.67
52-week range$0.01
$0.01$0.01

What Nexalin Technology does

Based in Houston, Texas, Nexalin Technology, Inc., founded in 2021, is a medical device firm dedicated to creating and advancing neurostimulation solutions. These products are designed to address mental health conditions within the United States and China. The company's primary offering, the Nexalin Device, is a licensed, non-invasive, and drug-free therapeutic option for managing anxiety and insomnia. This device functions by emitting a unique, patented frequency waveform that elicits a beneficial response from mid-brain structures implicated in various mental health disorders. Furthermore, Nexalin is currently developing its "Generation 2" medical device, which is undergoing clinical trials for potential treatment of opiate-related substance abuse, chronic pain, Alzheimer's disease, and dementia.

Key metrics

Market cap
$283,160
P/E (TTM)
-0.05
EPS (TTM)
$-0.28
Beta
4.04
Dividend yield
0.00%
Revenue / share
$0.31
50-day avg
$0.04
200-day avg
$0.20
52-week high
$0.01
52-week low
$0.01
CEO
Mark White

ETFs linked to NXLIW

Broad-market and Healthcare sector ETFs an investor holding Nexalin Technology is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how NXLIW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze NXLIW in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Nexalin Technology?
Nexalin Technology trades under the ticker NXLIW on NASDAQ.
Which exchange is NXLIW listed on?
NXLIW is listed on NASDAQ.
What sector does Nexalin Technology operate in?
Nexalin Technology is classified in the Healthcare sector (Medical - Devices industry).
How can PortView help analyze NXLIW in a portfolio?
PortView shows NXLIW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.